| The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis G Steinbach, PM Lynch, RKS Phillips, MH Wallace, E Hawk, GB Gordon, ... New England Journal of Medicine 342 (26), 1946-1952, 2000 | 3278 | 2000 |
| Effect of screening and adjuvant therapy on mortality from breast cancer DA Berry, KA Cronin, SK Plevritis, DG Fryback, L Clarke, M Zelen, ... New England Journal of Medicine 353 (17), 1784-1792, 2005 | 3103 | 2005 |
| CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma P Sharma, Y Shen, S Wen, S Yamada, AA Jungbluth, S Gnjatic, ... Proceedings of the National Academy of Sciences 104 (10), 3967-3972, 2007 | 608 | 2007 |
| A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis RKS Phillips, MH Wallace, PM Lynch, E Hawk, GB Gordon, BP Saunders, ... Gut 50 (6), 857-860, 2002 | 526 | 2002 |
| Detection of bladder cancer using a point-of-care proteomic assay HB Grossman, E Messing, M Soloway, K Tomera, G Katz, Y Berger, ... Jama 293 (7), 810-816, 2005 | 432 | 2005 |
| Multimodality management of urachal carcinoma: the MD Anderson Cancer Center experience AO Siefker-Radtke, J Gee, YU Shen, S Wen, D Daliani, RE Millikan, ... The Journal of urology 169 (4), 1295-1298, 2003 | 404 | 2003 |
| Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer A Stenzl, M Burger, Y Fradet, LA Mynderse, MS Soloway, JA Witjes, ... The Journal of urology 184 (5), 1907-1914, 2010 | 344 | 2010 |
| Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: an uncontrolled trial G Steinbach, R Ford, G Glober, D Sample, FB Hagemeister, PM Lynch, ... Annals of internal medicine 131 (2), 88-95, 1999 | 332 | 1999 |
| Surveillance for recurrent bladder cancer using a point-of-care proteomic assay HB Grossman, M Soloway, E Messing, G Katz, B Stein, V Kassabian, ... Jama 295 (3), 299-305, 2006 | 320 | 2006 |
| Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the MD Anderson cancer experience AO Siefker-Radtke, CP Dinney, NA Abrahams, C Moran, YU Shen, ... The Journal of urology 172 (2), 481-484, 2004 | 314 | 2004 |
| Role of detection method in predicting breast cancer survival: analysis of randomized screening trials Y Shen, Y Yang, LYT Inoue, MF Munsell, AB Miller, DA Berry Journal of the National Cancer Institute 97 (16), 1195-1203, 2005 | 312 | 2005 |
| DNA methylation and environmental exposures in human hepatocellular carcinoma L Shen, N Ahuja, Y Shen, NA Habib, M Toyota, A Rashid, JPJ Issa Journal of the National Cancer Institute 94 (10), 755-761, 2002 | 300 | 2002 |
| A prognostic gene expression signature in the molecular classification of chemotherapy-naive urothelial cancer is predictive of clinical outcomes from neoadjuvant chemotherapy … DJ McConkey, W Choi, YU Shen, IL Lee, S Porten, SF Matin, AM Kamat, ... European urology 69 (5), 855-862, 2016 | 289 | 2016 |
| Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma J Gao, N Navai, O Alhalabi, A Siefker-Radtke, MT Campbell, RS Tidwell, ... Nature medicine 26 (12), 1845-1851, 2020 | 252 | 2020 |
| Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy D Ng Tang, Y Shen, J Sun, S Wen, JD Wolchok, J Yuan, JP Allison, ... Cancer immunology research 1 (4), 229-234, 2013 | 222 | 2013 |
| Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy GP Midis, Y Shen, LB Owen-Schaub Cancer research 56 (17), 3870-3874, 1996 | 203 | 1996 |
| Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers FA Sinicrope, M Lemoine, L Xi, PM Lynch, KR Cleary, YU Shen, ... Gastroenterology 117 (2), 350-358, 1999 | 201 | 1999 |
| Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center SP Lynch, Y Shen, A Kamat, HB Grossman, JB Shah, RE Millikan, ... European urology 64 (2), 307-313, 2013 | 198 | 2013 |
| Correlation between CpG methylation profiles and hormone receptor status in breast cancers W Feng, L Shen, S Wen, DG Rosen, J Jelinek, X Hu, S Huan, M Huang, ... Breast cancer research 9, 1-13, 2007 | 197 | 2007 |
| Myelodysplastic syndrome is not merely “preleukemia” M Albitar, T Manshouri, Y Shen, D Liu, M Beran, HM Kantarjian, A Rogers, ... Blood, The Journal of the American Society of Hematology 100 (3), 791-798, 2002 | 184 | 2002 |
Wendy WoodwardProfessor, MD Anderson Cancer CenterEmail verificata su mdanderson.org